In the test group of 28 tumors from 25 VUS carriers, 25/28 were classified as MSI-H/dMMR from tumor sequencing, of which 23/25 (92%) were dMMR by MMR IHC (Table 3, Figure S2B). The gene discussed is MRC1; the disease is neoplasm.